Animal study on the effects of catalin on aftercataract and posterior capsule opacification

Ophthalmic Research

Volumn 31, Issue 2, 1999, Pages 140-142

  Biswas, Nihar R ^a   Mongre, Praveen K ^a   Das, Gopal K ^a   Sen, Seema ^a   Angra, Surinder K ^a   Vajpayee, Rasik B ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Catalin; Cataract; Posterior capsular opacification

Indexed keywords

ANTIBIOTIC AGENT; CATALIN; CORTICOSTEROID; CYCLOPLEGIC AGENT; EYE DROPS; PLACEBO;

AFTERCATARACT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CAPSULORHEXIS; CATARACT; CONFERENCE PAPER; EYE PHOTOGRAPHY; HISTOPATHOLOGY; LENS CAPSULE; NONHUMAN; POSTOPERATIVE PERIOD; PREVENTION; PRIORITY JOURNAL; RABBIT; SLIT LAMP; TOPICAL DRUG ADMINISTRATION;

ANIMALS; CAPSULORHEXIS; CATARACT; LENS CAPSULE, CRYSTALLINE; OPHTHALMIC SOLUTIONS; OXAZINES; RABBITS;

EID: 0032993924     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055526     Document Type: Conference Paper

References (15)

1. Suzuki T: Therapeutic effect of Catalin in senile cataract. Jpn Rev Clin Ophthalmol 1958;52:868-871.
2. Ikemoto F, Fukui S, Iwata S: Studies on transparent mechanism of lens. Membrane function of lens and its inhibition. Proc 50th Congr Pharmacol Soc Japan, Kanto Branch, Chiba 1974.
3. Ikemoto F, Fukui S, Iwata S: Studies on transparent mechanism of lens. 3. Reaction model of drugs in prevention of lens opacificative progress. Proc 45th Congr Pharmacol Soc Japan, Kiniki Branch, Tokushima 1974.
4. Okafor CO: Studies in the heterocyclic series. IV. Azaphenoxazines and related naturally occurring compounds. Int J Sulfur Chem 1971;6: 346-361.
5. Ogata K, Ikeda H, Fujisaki K: Behaviour of tryptophan solution by photooxidation and effect of phenoxazone compounds against fluorescence formation. Report of Senju Research Laboratory, 1974, No 334.
6. Narila F, Ikemoto F, Yamamoto Y, Ikeda H: Toxicity of lipoperoxide on lens. I. Influence on lens protein. Proc 89th Congr Pharmacol Soc Japan, Nagoya 1969.
7. Awata T, Terashima K: Screening for inhibitors of human placental aldose reductase. Report of Senju Research Laboratory, 1979, No 598.
8. Peyman GA, Sanders DR, Goldberg MF (eds): Principles and Practice of Ophthalmology. Philadelphia, Saunders Co, 1980, vol 1.
9. Okamoto T: Catalin® ophthalmic solution in the treatment of senile cataract: An evaluation by the trans-illumination photographic technique. Folia Ophthalmol Jpn 1975; 26:1334-1335.
10. Linuma T: Statistical analysis of the changes of visual acuity in untreated and Catalin-instilled eyes with senile cataract. Folia Ophthalmol Jpn 1977;28:847-858.
11. Komi T: Clinical evaluation of Catalin ophthalmic solution in the treatment of senile cataract. Jpn Clin Ophthalmol 1962;16:959-962.
12. Baba K: Chemotherapy of senile cataract. Jpn J Clin Ophthalmol 1958; 12:1119-1123.
13. Choudhury MI: Drug therapy of senile cataract with Catalin. Pak Med Forum 1970;5:33-38.
14. Oguini D, Kanematsu S: Reaction of 1,2-naphthoquinone with water-soluble protein of the lens. Report of Senju Research Laboratory, 1974, No 313.
15. Nakagaki M, Koga N, Iwata S: Biophysico-chemical studies of phenoxazone compounds. IV. Membrane constants of bovine eye lens capsule and the effect of phenoxazone compounds. J Pharm Soc Japan 1963; 83:279-282.